Close Menu

By Justin Petrone

Royal Philips Electronics and bioMérieux plan to jointly develop fully automated handheld diagnostic biochips for hospital use that can be deployed at the point of care. The firms are aiming for eventual adoption of their chips in critical care settings within hospitals.

The deal is the latest for Philips, which is increasingly looking for partners to bring applications to market on its internally developed biosensor and microarray platforms.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.